- Home
- RCMT vs DERM Comparison
RCMT vs DERM Comparison
Compare RCMT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- DERM
- Stock Information
- Founded
- RCMT 1971
- DERM 2014
- Country
- RCMT United States
- DERM United States
- Employees
- RCMT N/A
- DERM N/A
- Industry
- RCMT Professional Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- RCMT Consumer Discretionary
- DERM Health Care
- Exchange
- RCMT Nasdaq
- DERM Nasdaq
- Market Cap
- RCMT 200.2M
- DERM 190.7M
- IPO Year
- RCMT N/A
- DERM 2021
- Fundamental
- Price
- RCMT $23.07
- DERM $7.26
- Analyst Decision
- RCMT Strong Buy
- DERM Strong Buy
- Analyst Count
- RCMT 2
- DERM 3
- Target Price
- RCMT $33.50
- DERM $12.67
- AVG Volume (30 Days)
- RCMT 35.7K
- DERM 93.1K
- Earning Date
- RCMT 11-06-2025
- DERM 11-11-2025
- Dividend Yield
- RCMT N/A
- DERM N/A
- EPS Growth
- RCMT N/A
- DERM N/A
- EPS
- RCMT 1.76
- DERM N/A
- Revenue
- RCMT $299,916,000.00
- DERM $56,397,000.00
- Revenue This Year
- RCMT $15.03
- DERM $26.16
- Revenue Next Year
- RCMT $7.49
- DERM $45.27
- P/E Ratio
- RCMT $13.60
- DERM N/A
- Revenue Growth
- RCMT 11.01
- DERM N/A
- 52 Week Low
- RCMT $13.18
- DERM $3.54
- 52 Week High
- RCMT $28.27
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- RCMT 28.94
- DERM 50.72
- Support Level
- RCMT $23.51
- DERM $6.91
- Resistance Level
- RCMT $25.75
- DERM $7.79
- Average True Range (ATR)
- RCMT 0.87
- DERM 0.31
- MACD
- RCMT -0.42
- DERM 0.03
- Stochastic Oscillator
- RCMT 0.00
- DERM 47.79
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.